Zobrazeno 1 - 10
of 43
pro vyhledávání: '"I Cánovas Olmos"'
Autor:
C Riesco Barcena, S Leal Rodríguez, ME Acosta de la Vega, E Grau García, C Pávez Perales, AV Huaylla Quispe, M De la Rubia, P Muñoz Martínez, L Mas Sánchez, I Martínez Cordellat, C Nájera Herranz, R Negueroles Albuixech, F Ortiz-Sanjuán, E Vicens Bernabéu, I Cánovas Olmos, JJ Fragio Gil, L González Puig, J Oller Rodríguez, J Ivorra Cortés, JA Román Ivorra
Publikováno v:
Friday 07 October 2022 from 13:00 to 14:10.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e77cab15ba95f3540fe51474e3862404
https://doi.org/10.1136/lupus-2022-elm2022.194
https://doi.org/10.1136/lupus-2022-elm2022.194
Autor:
E Grau García, L Gomez-Lechón Quirós, C Riesco Barcena, AV Huaylla Quispe, S Leal Rodríguez, C Pávez Perales, L Mas Sanchez, P Muñoz Martínez, M De La Rubia Navarro, I Cánovas Olmos, J Ivorra Cortés, JJ Fragio Gil, L González Puig, I Martínez Cordellat, C Nájera Herranz, R Negueroles Albuixech, JE Oller Rodríguez, FM Ortiz-Sanjuán, E Vicens Bernabéu, JA Roman Ivorra
Publikováno v:
Thursday 06 October 2022 from 13:00 to 14:10.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::464e96436327d7bb0f81bf32ed5654d4
https://doi.org/10.1136/lupus-2022-elm2022.95
https://doi.org/10.1136/lupus-2022-elm2022.95
Autor:
C. Riesco Bárcena, S. Leal Rodriguez, M. E. Acosta, E. Grau García, C. Pávez Perales, A. V. Huaylla Quispe, M. De la Rubia Navarro, P. Muñoz Martinez, L. Mas Sanchez, I. Martínez Cordellat, C. Nájera Herranz, R. Negueroles Albuixech, F. Ortiz-Sanjuán, E. Vicens Bernabeu, I. Cánovas Olmos, J. J. Fragío Gil, L. Gonzalez Puig, J. E. Oller Rodríguez, J. Ivorra Cortés, J. A. Román Ivorra
Publikováno v:
Annals of the Rheumatic Diseases. 81:328-329
BackgroundDuring the first months of the Sars-CoV-2 pandemic, antimalarial drugs were the central axis of the treatment of patients with acute respiratory infection. After that, several studies reported a risk of prolongation of corrected QT interval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b67720982b59e9613917d9f7a3e8a243
https://doi.org/10.1136/annrheumdis-2022-eular.2847
https://doi.org/10.1136/annrheumdis-2022-eular.2847
Autor:
F. Ortiz-Sanjuán, S. Leal Rodriguez, E. Grau García, C. Riesco Barcena, A. V. Huaylla Quispe, C. Pávez Perales, M. De la Rubia Navarro, I. Martínez Cordellat, L. Mas Sanchez, P. Muñoz Martinez, C. Nájera Herranz, R. Negueroles Albuixech, J. E. Oller Rodríguez, E. Vicens Bernabeu, I. Cánovas Olmos, J. J. Fragío Gil, L. Gonzalez Puig, J. Ivorra Cortés, J. A. Román Ivorra
Publikováno v:
Annals of the Rheumatic Diseases. 81:250.2-250
BackgroundInterstitial lung disease (ILD) is a frequent complication of systemic sclerosis (SSc) and is often progressive and has a poor prognosis. A restrictive ventilatory defect could suggest ILD either alone or in combination with pulmonary arter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efe3c0f15224ce9040d60eb31151252c
https://doi.org/10.1136/annrheumdis-2022-eular.3085
https://doi.org/10.1136/annrheumdis-2022-eular.3085
Autor:
E. Grau García, J. J. Fragío Gil, R. González Mazarío, P. Muñoz Martinez, L. Mas Sanchez, C. Pávez Perales, S. Leal Rodriguez, A. V. Huaylla Quispe, C. Riesco Barcena, M. De la Rubia Navarro, F. Ortiz-Sanjuán, I. Martínez Cordellat, J. E. Oller Rodríguez, R. Negueroles Albuixech, J. Ivorra Cortés, L. Gonzalez Puig, E. Vicens Bernabeu, I. Cánovas Olmos, C. Nájera Herranz, J. A. Román Ivorra
Publikováno v:
Annals of the Rheumatic Diseases. 81:1334.1-1334
BackgroundGender differences in demographic and clinical features may have a direct impact in patient prognosis.ObjectivesWe aimed to investigate gender differences in disease manifestations, comorbidities and treatment among patients who had started
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b496e573ebb72b6506ab4613a94b26b9
https://doi.org/10.1136/annrheumdis-2022-eular.3917
https://doi.org/10.1136/annrheumdis-2022-eular.3917
Autor:
R. González Mazarío, J. J. Fragío Gil, L. Mas Sanchez, P. Muñoz Martinez, F. Ortiz-Sanjuán, C. Pávez Perales, S. Leal Rodriguez, C. Riesco Barcena, A. V. Huaylla Quispe, M. De la Rubia Navarro, L. Gonzalez Puig, E. Grau García, J. E. Oller Rodríguez, I. Martínez Cordellat, R. Negueroles Albuixech, E. Vicens Bernabeu, J. Ivorra Cortés, C. Nájera Herranz, I. Cánovas Olmos, J. A. Román Ivorra
Publikováno v:
Annals of the Rheumatic Diseases. 81:1286.1-1286
BackgroundRecent published data have emerged some concerns about safety of Janus kinase (JAK) inhibitors and FDA have established prescribing restrictions.ObjectivesThe aim of this study was to analyze the safety profile of current approved JAK inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::367a56c14def5a47b84f1c0681727e3b
https://doi.org/10.1136/annrheumdis-2022-eular.5038
https://doi.org/10.1136/annrheumdis-2022-eular.5038
Autor:
P. Martinez Calabuig, R. González Mazarío, J. J. Fragío Gil, E. Grau García, C. Pávez Perales, S. Leal Rodriguez, C. Riesco Barcena, A. V. Huaylla Quispe, L. Mas Sanchez, P. Muñoz Martinez, J. E. Oller Rodríguez, E. Vicens Bernabeu, R. Negueroles Albuixech, J. Ivorra Cortés, F. Ortiz-Sanjuán, M. De la Rubia Navarro, L. Gonzalez Puig, I. Martínez Cordellat, C. Nájera Herranz, I. Cánovas Olmos, J. A. Román Ivorra
Publikováno v:
Annals of the Rheumatic Diseases. 81:1244-1244
BackgroundThe risk of cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA) is higher than individuals from the general population due to chronic inflammation. Current CV risk screening and management strategies underestimate the ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2dd737952de9e0ef7f5c1cc8ddd578b
https://doi.org/10.1136/annrheumdis-2022-eular.5306
https://doi.org/10.1136/annrheumdis-2022-eular.5306
Autor:
R. González Mazarío, P. Martinez Calabuig, J. J. Fragío Gil, E. Grau García, C. Pávez Perales, S. Leal Rodriguez, C. Riesco Barcena, A. V. Huaylla Quispe, L. Mas Sanchez, P. Muñoz Martinez, J. E. Oller Rodríguez, E. Vicens Bernabeu, F. Ortiz-Sanjuán, R. Negueroles Albuixech, M. De la Rubia Navarro, I. Martínez Cordellat, L. Gonzalez Puig, J. Ivorra Cortés, C. Nájera Herranz, I. Cánovas Olmos, J. A. Román Ivorra
Publikováno v:
Annals of the Rheumatic Diseases. 81:1287.2-1288
BackgroundThe risk of cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA) is higher than individuals from the general population. This excess risk might be explained by the chronic inflammation.ObjectivesTo assess the Cardiovascul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3df586389e8adf4c3f4e031ca73a68bf
https://doi.org/10.1136/annrheumdis-2022-eular.5225
https://doi.org/10.1136/annrheumdis-2022-eular.5225
Autor:
J. E. Oller Rodríguez, E. Grau García, S. Leal Rodriguez, P. Muñoz Martinez, L. Mas Sanchez, C. Riesco Barcena, A. V. Huaylla Quispe, C. Pávez Perales, M. De la Rubia Navarro, I. Martínez Cordellat, C. Nájera Herranz, R. Negueroles Albuixech, F. Ortiz-Sanjuán, E. Vicens Bernabeu, I. Cánovas Olmos, J. J. Fragío Gil, L. Gonzalez Puig, J. Ivorra Cortés, J. A. Román Ivorra
Publikováno v:
Annals of the Rheumatic Diseases. 81:1635.2-1635
BackgroundVertebral fractures entail a notorious social and health problem, and their presence is the greatest risk factor for the appearance of a new vertebral fracture. Despite the availability of different drugs for secondary prevention, there are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b6399a668a32862b960c2735dfc1384
https://doi.org/10.1136/annrheumdis-2022-eular.3312
https://doi.org/10.1136/annrheumdis-2022-eular.3312
Autor:
M. De la Rubia Navarro, J. Ivorra Cortés, E. Grau García, L. Gonzalez Puig, R. Negueroles Albuixech, I. Martínez Cordellat, F. Ortiz-Sanjuán, J. E. Oller Rodríguez, S. Leal Rodriguez, C. Pávez Perales, J. J. Fragío Gil, E. Vicens Bernabeu, C. Riesco Barcena, A. V. Huaylla Quispe, L. Mas Sanchez, P. Muñoz, C. Nájera Herranz, I. Cánovas Olmos, J. A. Román Ivorra
Publikováno v:
Annals of the Rheumatic Diseases. 81:1345.2-1346
BackgroundSystemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease. Kidney affection appears in 40-50% of SLE patients and may condition the prognosis. Belimumab is a monoclonal antibody approved for SLE since 2011, but it had no lupu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb1b8b763c08e02c2e85044edc8bfa27
https://doi.org/10.1136/annrheumdis-2022-eular.2944
https://doi.org/10.1136/annrheumdis-2022-eular.2944